Article info
Inflammation and inflammatory bowel disease
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines
- Correspondence to:
Professor M J S Langman, Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK;
m.j.s.langman{at}bham.ac.uk
Citation
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines
Publication history
- Accepted January 28, 2002
- First published October 1, 2002.
Online issue publication
October 01, 2002
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2002 by Gut